H0344R1939A04515 NAD:EJH 01/17/20 #90 A04515
AMENDMENTS TO HOUSE RESOLUTION NO. 344
Sponsor: REPRESENTATIVE CRUZ
Printer's No. 1939
Amend Resolution, page 1, lines 1 through 4, by striking out
all of said lines and inserting
Urging pharmaceutical companies, manufacturers and distributors
of prescription opioid drugs to fully cooperate with the
Pennsylvania Office of Attorney General in reaching financial
settlements and legal resolutions that reflect the severe,
irreversible harm suffered by tens of thousands of
Pennsylvania families who have lost loved ones to the opioid
crisis and to substance use disorder.
Amend Resolution, page 1, lines 9 and 10, by striking out
"and the" and inserting a comma
Amend Resolution, page 1, line 10, by striking out "opioid"
and inserting
opioids, including
Amend Resolution, page 1, line 10, by inserting after "and"
carfentanyl, and
Amend Resolution, page 3, line 12, by striking out
"addiction" and inserting
substance use disorder
Amend Resolution, page 3, line 15, by striking out "the"
where it occurs the second time
Amend Resolution, page 3, line 23, by striking out "crisis"
and inserting
epidemic
Amend Resolution, page 3, line 23, by striking out "epidemic"
and inserting
2020/90NAD/HR0344A04515 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
crisis
Amend Resolution, page 3, line 29, by inserting after "to"
prescription
Amend Resolution, page 4, line 26, by inserting after "of"
prescription
Amend Resolution, page 4, line 28, by striking out "epidemic"
and inserting
crisis
Amend Resolution, page 5, line 3, by striking out "five" and
inserting
eight
Amend Resolution, page 5, line 14, by inserting after
"individuals"
and companies
Amend Resolution, page 5, line 14, by inserting after "who"
produce,
Amend Resolution, page 5, line 14, by inserting after
"supply"
and distribute
Amend Resolution, page 5, line 15, by striking out "to co-
conspirators"
Amend Resolution, page 5, lines 23 and 24, by striking out
"section 841 of Title 18 of the United States Code" and
inserting
codified at 18 U.S.C. ยง 842
Amend Resolution, page 5, line 26, by inserting after
"manufacturers"
of prescription opioids
Amend Resolution, page 6, line 5, by striking out "Certain"
and inserting
It was reported that during the last decade, certain
2020/90NAD/HR0344A04515 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Amend Resolution, page 6, lines 5 and 6, by striking out "and
continue to spend"
Amend Resolution, page 6, line 19, by striking out "opioid
medications" and inserting
prescription opioids
Amend Resolution, page 6, line 19, by inserting after
"companies,"
manufacturers and
Amend Resolution, page 6, lines 19 and 20, by striking out
"and manufacturers have"
Amend Resolution, page 6, line 20, by inserting after "and"
, in some cases,
Amend Resolution, page 6, lines 24 through 30, by striking
out all of said lines
Amend Resolution, page 7, line 1, by inserting after
"companies,"
manufacturers and
Amend Resolution, page 7, line 2, by striking out "and
manufacturers" and inserting
of prescription opioids
Amend Resolution, page 7, line 2, by striking out "be ending"
and inserting
end
Amend Resolution, page 7, line 3, by inserting after "of"
marketing and
Amend Resolution, page 7, line 3, by striking out "opioid
medications" and inserting
the use of prescription opioids
Amend Resolution, page 7, lines 3 and 4, by striking out
"prescribers through" and inserting
2020/90NAD/HR0344A04515 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
health care providers by
Amend Resolution, page 7, line 4, by striking out "this
process" and inserting
the aggressive marketing of prescription opioids
Amend Resolution, page 7, line 4, by striking out "occur" and
inserting
cease
Amend Resolution, page 7, line 9, by inserting after
"protect"
the health, safety and general welfare of
Amend Resolution, page 7, line 12, by inserting after
"companies,"
manufacturers and
Amend Resolution, page 7, line 12, by striking out "and
manufacturers," and inserting
of prescription opioids,
Amend Resolution, page 7, line 16, by striking out "and" and
inserting a comma
Amend Resolution, page 7, line 17, by inserting after
"manufacturers"
and distributors of prescription drugs
Amend Resolution, page 7, line 17, by striking out "epidemic"
and inserting
crisis
Amend Resolution, page 7, line 27, by striking out ", and is
currently pending"
Amend Resolution, page 7, line 28, by inserting after
"companies,"
manufacturers and
Amend Resolution, page 7, line 28, by striking out "and
2020/90NAD/HR0344A04515 - 4 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
manufacturers" and inserting
of prescription opioids
Amend Resolution, page 8, line 1, by striking out "those who"
and inserting
the pharmaceutical companies, manufacturers and distributors
that
Amend Resolution, page 8, line 8, by inserting after "of"
prescription
Amend Resolution, page 8, lines 9 through 30; page 9, lines 1
through 3; by striking out all of said lines on said pages and
inserting
WHEREAS, In 2019, the Pennsylvania Office of Attorney General
filed two lawsuits against Purdue Pharma, accusing the company
and its owners of a multifaceted, illegal effort to market
OxyContin in this Commonwealth; and
WHEREAS, Purdue Pharma filed for Chapter 11 bankruptcy in
September 2019 as part of a tentative deal to settle more than
2,000 opioid lawsuits filed by states, local governments and
Native American tribes; and
WHEREAS, A collaborative 41-state investigation led by the
Pennsylvania Office of Attorney General resulted in a $48
billion agreement in principle from Cardinal Health, McKesson,
AmerisourceBergen, Johnson & Johnson and Teva for their roles in
fueling the opioid crisis; and
WHEREAS, The Commonwealth will receive more than $53 million
as part of a nationwide settlement against Reckitt Benckiser
Group for the improper marketing of Suboxone and practices to
defraud Medicaid systems in this Commonwealth; therefore be it
RESOLVED, That the House of Representatives urge the
pharmaceutical companies, manufacturers and distributors of
prescription opioid drugs to fully cooperate with the
Pennsylvania Office of Attorney General in reaching financial
settlements and legal resolutions that reflect the severe,
irreversible harm suffered by tens of thousands of Pennsylvania
families who have lost loved ones to the opioid crisis and to
substance use disorder; and be it further
RESOLVED, That the House of Representatives applaud the work
of the Pennsylvania Office of Attorney General in combating the
opioid crisis in Pennsylvania through its ongoing bipartisan,
multistate investigation and litigation in pursuit of justice
for the individuals and families across this Commonwealth that
have been affected; and be it further
RESOLVED, That the House of Representatives urge the
Pennsylvania Office of Attorney General, as the top law
2020/90NAD/HR0344A04515 - 5 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
enforcement officer in this Commonwealth, to continue to pursue
all available legal remedies to hold the pharmaceutical
companies, manufacturers and distributors of prescription
opioids accountable for their practices that caused or
contributed to the opioid crisis in this Commonwealth.
2020/90NAD/HR0344A04515 - 6 -
1
2
3
4
5
See A04515 in
the context
of HR0344